Investing Profile

Mike Pellini

InvestorVC

Managing Partner at Section 32

s32.com/team/mike-pellini-mdCalifornia

Your Intro Paths to Mike Pellini

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Mike is a member of

Boston College Network

108 CONNECTIONS

Drexel University's LeBow College of Business Network

12 CONNECTIONS

Drexel University's LeBow College of Business Network

12 CONNECTIONS

Find Mike Pellini on

Current Investing Position

Section 32 Managing Partner

Investment Range

$10K - $50K

Sweet Spot

$25K

Investments On Record

Current Fund Size

$740M

Mike Pellini is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Series B)BioTech (Seed)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Mike Pellini's Investments On Record (14)

Company	StageDateRound Size	Total Raised
Octave	Series CSep 2025$36M Series BJul 2023$33M Series BDec 2020$32M Series AJul 2018$14M	$190M
Co-investors: Brett Queener (Bonfire Ventures), David Rubin (Merck Global Health Innovation Fund), Saurabh Bhansali (Health Velocity Capital), Michael Rubin (Northpond Ventures), Julian Harris (Deerfield Management), Michael G. Rubin
AltPep	Series BJun 2023$53M	$53M
MedCrypt	Series BNov 2022$25M Series AMay 2019$6M	$33M
Co-investors: Nihal Mehta (ENIAC Ventures), Hadley Harris (ENIAC Ventures), Tim Young (ENIAC Ventures), Vic Singh (ENIAC Ventures), Oliver Keown (Intuitive Ventures)
Nucleai	Series BMar 2022$33M	$94M
Co-investors: Noga Yerushalmi (MDC Ventures (formerly KBS Ventures)), Sigalit Klimovsky (Grove Ventures), Emanuel Timor (Vertex Ventures Israel), Cris De Luca (Sanofi Ventures), Andy Harrison (Section 32)
ONI	Series BDec 2021$75M	$75M
Co-investors: David Schwab (Sierra Ventures), Paul Conley (Paladin Capital Group), Keith Crandell (ARCH Venture Partners), Vasudev Bailey (Artis Ventures (AV))
Exai Bio	Series ADec 2021$68M	$68M
ScienceIO	SeedOct 2021$8M	$8M
Co-investors: Jack Altman (Benchmark), Jeffrey Silverstein (Andreessen Horowitz), Josh Buckley (Buckley Ventures), Oliver Cameron (Odyssey Ventures), Harry Hurst (Pipeline Capital Partners), Ankur Nagpal (Vibe Capital), Packy McCormick (Not Boring Capital), Lachy Groom (Physical Intelligence), Todd Goldberg (Todd and Rahul's Angel Fund), Turner Novak (Banana Capital), Rahul Vohra (Todd and Rahul's Angel Fund), Jude Gomila (Golden (Recursion Inc)), Scott Belsky (A24)
TwinStrand Biosciences	Series BMay 2021$50M	$50M
Co-investors: Somar Somasegar (Madrona Venture Group)

Mike Pellini's Experience

Managing Partner Section 322017 - Present

Chairman Foundation MedicinePresent

CEO Foundation MedicinePresent

Managing Partner Clarient, Inc.Present

Managing Partner S32Present

Chairman Foundation Medicine, Inc.2017 - 2018

CEO Foundation Medicine, Inc.2011 - 2017

President and COO Clarient, Inc.2007 - 2011

Mike Pellini's Education

Thomas Jefferson University

Boston College Bachelor’s Degree Economics

Drexel University's LeBow College of Business Master of Business Administration - MBA Finance

Drexel University's LeBow College of Business MBA

Investors who invest with Mike Pellini

Scouts & Angels Affiliated With Mike Pellini